Rivaroxaban Versus Warfarin in Patients with Mechanical Heart Valves: Open-Label, Proof-of-Concept trial-The RIWA study.
Andre Rodrigues DuraesYasmin de Souza Lima BitarIgor Santos SchonhofenKethyren Santos Oliveira TravassosLarissa Vitória PereiraJose Admirço Lima FilhoMansueto Gomes NetoRoque Aras JuniorLeonardo RoeverPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2020)
NCT03566303.
Keyphrases
- atrial fibrillation
- open label
- venous thromboembolism
- phase iii
- phase ii
- clinical trial
- study protocol
- heart failure
- direct oral anticoagulants
- pulmonary embolism
- randomized controlled trial
- squamous cell carcinoma
- aortic valve replacement
- radiation therapy
- coronary artery disease
- phase ii study
- left ventricular
- aortic stenosis
- ejection fraction